Cardio-ankle vascular index for predicting cardiovascular morbimortality and determinants for its progression in the prospective advanced approach to arterial stiffness (TRIPLE-A-Stiffness) study
Language English Country Netherlands Media print-electronic
Document type Journal Article, Multicenter Study
PubMed
38632024
PubMed Central
PMC11121166
DOI
10.1016/j.ebiom.2024.105107
PII: S2352-3964(24)00142-7
Knihovny.cz E-resources
- Keywords
- Arterial stiffness, Cardio-ankle vascular index, Cardiovascular morbimortality, Risk factor,
- MeSH
- Cardio Ankle Vascular Index * MeSH
- Adult MeSH
- Cardiovascular Diseases * mortality diagnosis etiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Longitudinal Studies MeSH
- Prognosis MeSH
- Disease Progression MeSH
- Prospective Studies MeSH
- Heart Disease Risk Factors MeSH
- Risk Factors MeSH
- ROC Curve MeSH
- Aged MeSH
- Vascular Stiffness * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
BACKGROUND: The cardio-ankle vascular index (CAVI) measure of arterial stiffness is associated with prevalent cardiovascular risk factors, while its predictive value for cardiovascular events remains to be established. The aim was to determine associations of CAVI with cardiovascular morbimortality (primary outcome) and all-cause mortality (secondary outcome), and to establish the determinants of CAVI progression. METHODS: TRIPLE-A-Stiffness, an international multicentre prospective longitudinal study, enrolled >2000 subjects ≥40 years old at 32 centres from 18 European countries. Of these, 1250 subjects (55% women) were followed for a median of 3.82 (2.81-4.69) years. FINDINGS: Unadjusted cumulative incidence rates of outcomes according to CAVI stratification were higher in highest stratum (CAVI > 9). Cox regression with adjustment for age, sex, and cardiovascular risk factors revealed that CAVI was associated with increased cardiovascular morbimortality (HR 1.25 per 1 increase; 95% confidence interval, CI: 1.03-1.51) and all-cause mortality (HR 1.37 per 1 increase; 95% CI: 1.10-1.70) risk in subjects ≥60 years. In ROC analyses, CAVI optimal threshold was 9.25 (c-index 0.598; 0.542-0.654) and 8.30 (c-index 0.565; 0.512-0.618) in subjects ≥ or <60 years, respectively, to predict increased CV morbimortality. Finally, age, mean arterial blood pressure, anti-diabetic and lipid-lowering treatment were independent predictors of yearly CAVI progression adjusted for baseline CAVI. INTERPRETATION: The present study identified additional value for CAVI to predict outcomes after adjustment for CV risk factors, in particular for subjects ≥60 years. CAVI progression may represent a modifiable risk factor by treatments. FUNDING: International Society of Vascular Health (ISVH) and Fukuda Denshi, Japan.
Almazov Federal Medical Research Centre St Petersburg Russia
Cardiometabolic Centre Dept of Angiology Szent Imre University Teaching Hospital Budapest Hungary
Department of Internal Medicine Hospital Mutua Terrassa University of Barcelona Terrassa Spain
Department of Medical Clinical Pharmacology University of Debrecen Hungary
Department of Medicine Section of Geriatric Medicine University of Verona Italy
Foundation Medical Research Institutes Paris France
Inserm U1116 Nancy France; Université de Lorraine CHRU Nancy University Hospital of Nancy France
Institute of Cardiology Centre of Preventive Cardiology Yerevan Armenia
Institute of Cardiology Kiev Ukraine
Medical Faculty University of Belgrade and Cardiovascular Institute Dedinje Belgrade Serbia
P Stradins University Hospital Cardiology Centre Riga Latvia
Paris Descartes University AP HP Diagnosis and Therapeutic Center Hôtel Dieu Paris France
Scientific and Research Institute of Cardiology and Internal Diseases Almaty Kazakhstan
Université de Lorraine CHRU Nancy University Hospital of Nancy France
See more in PubMed
Shirai K., Utino J., Otsuka K., Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI) J Atheroscler Thromb. 2006;13:101–107. PubMed
Topouchian J., Labat C., Gautier S., et al. Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study. J Hypertens. 2018;36:824–833. PubMed PMC
Gomez-Sanchez L., Garcia-Ortiz L., Patino-Alonso M.C., et al. The association between the cardio-ankle vascular index and other parameters of vascular structure and function in caucasian adults: MARK study. J Atheroscler Thromb. 2015;22:901–911. PubMed
Kadoglou N.P.E., Moulakakis K.G., Mantas G., et al. The association of arterial stiffness with significant carotid atherosclerosis and carotid plaque vulnerability. Angiology. 2022;73:668–674. PubMed
Matsushita K., Ding N., Kim E.D., et al. Cardio-ankle vascular index and cardiovascular disease: systematic review and meta-analysis of prospective and cross-sectional studies. J Clin Hypertens. 2019;21:16–24. PubMed PMC
Williams B., Mancia G., Spiering W., et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of hypertension (ESH) Eur Heart J. 2018;39:3021–3104. PubMed
Shirai K., Takahara A. In: Cardio-ankle vascular index overview & clinical application. Asmar R., editor. 2021. The principles of cardio-ankle vascular index (CAVI) and its features; pp. 19–24.
Kubota Y., Maebuchi D., Takei M., et al. Cardio-Ankle Vascular Index is a predictor of cardiovascular events. Artery Research. 2011;5:91–96.
Miyoshi T., Ito H., Shirai K., et al. Predictive value of the cardio-ankle vascular index for cardiovascular events in patients at cardiovascular risk. J Am Heart Assoc. 2021;10 PubMed PMC
Spronck B., Obeid M.J., Paravathaneni M., et al. Predictive ability of pressure-corrected arterial stiffness indices: comparison of pulse wave velocity, cardio-ankle vascular index (CAVI), and CAVI0. Am J Hypertens. 2022;35:272–280. PubMed PMC
Schillaci G., Battista F., Settimi L., Anastasio F., Pucci G. Cardio-ankle vascular index and subclinical heart disease. Hypertens Res. 2015;38:68–73. PubMed
Laucevicius A., Ryliskyte L., Balsyte J., et al. Association of cardio-ankle vascular index with cardiovascular risk factors and cardiovascular events in metabolic syndrome patients. Medicina (Kaunas) 2015;51:152–158. PubMed
Sato Y., Nagayama D., Saiki A., et al. Cardio-ankle vascular index is independently associated with future cardiovascular events in outpatients with metabolic disorders. J Atheroscler Thromb. 2016;23:596–605. PubMed
Satoh-Asahara N., Kotani K., Yamakage H., et al. Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: a multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: joms) Atherosclerosis. 2015;242:461–468. PubMed
Otsuka K., Fukuda S., Shimada K., et al. Serial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease. Hypertens Res. 2014;37:1014–1020. PubMed
Miyoshi T., Ito H., Horinaka S., Shirai K., Higaki J., Orimo H. Protocol for evaluating the cardio-ankle vascular index to predict cardiovascular events in Japan: a prospective multicenter cohort study. Pulse (Basel) 2017;4:11–16. PubMed PMC
Sahebkar A., Pecin I., Tedeschi-Reiner E., Derosa G., Maffioli P., Reiner Z. Effects of statin therapy on augmentation index as a measure of arterial stiffness: a systematic review and meta-analysis. Int J Cardiol. 2016;212:160–168. PubMed
Asmar R. Principles and usefulness of the cardio-ankle vascular index (CAVI): a new global arterial stiffness index. Eur Heart J Suppl. 2017;19:B4–B10.
VanderWeele T.J. Principles of confounder selection. Eur J Epidemiol. 2019;34:211–219. PubMed PMC